Leptospirosis in Dogs: Clinical Signs, Diagnosis, and Zoonotic Implications

Introduction

Leptospirosis is a globally distributed bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. In dogs, the disease presents a diagnostic challenge due to its variable clinical manifestations, which range from subclinical infection to acute multi-organ failure. The pathogen is maintained in the environment through reservoir hosts, primarily rodents and wildlife, and dogs serve as both accidental hosts and potential sentinels for human exposure [1, 2]. The zoonotic implications of canine leptospirosis are substantial, as infected dogs can shed leptospires in urine and contribute to environmental contamination [3, 4]. This article provides an exhaustive review of the clinical signs, diagnostic modalities, serovar epidemiology, vaccination protocols, and public health risks associated with canine leptospirosis, with an emphasis on the One Health framework.

Etiology and Pathogenesis

Leptospira are obligate aerobic spirochetes belonging to the family Leptospiraceae. Pathogenic species, primarily Leptospira interrogans sensu stricto and Leptospira kirschneri, are classified into serogroups based on lipopolysaccharide (LPS) antigens and further into serovars. The serovars most commonly associated with canine disease include Canicola, Icterohaemorrhagiae, Grippotyphosa, Pomona, and Australis [3, 5, 6]. The outer membrane of leptospires contains lipoproteins such as Loa22, which is a critical virulence factor involved in host cell adhesion and immune evasion [7].

Transmission occurs through direct contact with infected urine or indirectly via contaminated water, soil, or fomites. Leptospires penetrate mucous membranes or abraded skin and enter the bloodstream, leading to a leptospiremic phase. During this phase, the organism disseminates to multiple organs, including the kidneys, liver, lungs, and eyes. The host immune response, particularly opsonizing antibodies, clears the organism from most tissues, but leptospires can persist in the renal tubules, leading to chronic shedding in urine [1, 8]. The pathogenesis of renal injury involves interstitial nephritis and tubular necrosis, while hepatic involvement manifests as hepatocellular dissociation and cholestasis.

Clinical Signs

The clinical presentation of canine leptospirosis is highly variable and depends on the infecting serovar, the infectious dose, and the host immune status. Subclinical infections are common, particularly in endemic regions [9, 10]. Acute disease typically presents with fever, lethargy, anorexia, vomiting, and abdominal pain. Polydipsia and polyuria may reflect early renal tubular dysfunction.

Organ-Specific Manifestations

Renal involvement is the most consistent finding. Acute kidney injury (AKI) develops in a significant proportion of clinical cases, characterized by azotemia, isosthenuria, and proteinuria. Oliguric or anuric renal failure carries a guarded prognosis [1, 3].

Hepatic involvement manifests as icterus, elevated liver enzyme activities (alanine aminotransferase, alkaline phosphatase), and hyperbilirubinemia. Hepatic dysfunction may occur concurrently with or independently of renal disease.

Pulmonary involvement has been increasingly recognized. Serial evaluation of clinical, functional, and structural pulmonary changes in dogs with leptospirosis has demonstrated that pulmonary hemorrhage and acute respiratory distress syndrome (ARDS) can occur, often with rapid progression [1]. Radiographic findings include diffuse interstitial to alveolar patterns, and computed tomography may reveal ground-glass opacities.

Other clinical signs include myalgia, stiffness, conjunctival suffusion, and uveitis. Coagulopathies, including thrombocytopenia and prolonged clotting times, are common and may contribute to petechiation and epistaxis [11].

Biomarkers

Serum sialic acid has been investigated as a biomarker of inflammation and infection in veterinary medicine. Elevated total sialic acid levels correlate with the acute phase response in leptospirosis and may aid in distinguishing infectious from non-infectious inflammatory conditions [11].

Diagnostic Methods

The diagnosis of canine leptospirosis relies on a combination of serological, molecular, and culture-based methods. No single test provides perfect sensitivity and specificity, and a multi-modal approach is recommended.

Microscopic Agglutination Test (MAT)

The microscopic agglutination test (MAT) remains the reference standard for serological diagnosis. The MAT detects antibodies against a panel of live leptospiral serovars. A single titer of 1:800 or greater in a dog with compatible clinical signs is considered supportive of active infection, while a four-fold rise in paired acute and convalescent titers confirms seroconversion [3, 6]. Limitations of the MAT include the need for maintaining live cultures, subjective interpretation, and cross-reactivity between serogroups. The MAT cannot distinguish between infection and vaccination, particularly in recently vaccinated dogs.

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA-based methods detect IgM and IgG antibodies against leptospiral antigens. IgM detection is useful for identifying acute infection, while IgG may indicate past exposure or vaccination. Commercial ELISA kits are available, but their performance varies by geographic region and circulating serovars. A recombinant Loa22-gold nanoparticle based lateral flow assay has been developed for the serodiagnosis of leptospirosis in canine and bovine samples, offering a rapid, point-of-care alternative to laboratory-based ELISA [7].

Polymerase Chain Reaction (PCR)

PCR assays targeting conserved genes such as lipL32, secY, or 16S rRNA provide direct detection of leptospiral DNA in blood, urine, or tissue samples. Real-time PCR (qPCR) offers quantitative data and high analytical sensitivity. PCR is particularly valuable during the acute leptospiremic phase when serology may be negative [5, 12]. Urine PCR is recommended for detecting renal shedding, but the sensitivity is reduced in dogs with low urine pH or after antibiotic therapy. Molecular characterization of outbreak strains using PCR and sequencing has been instrumental in epidemiological investigations [3, 13].

Culture

Isolation of Leptospira from blood, urine, or tissue is definitive but technically demanding and slow. Specialized media such as Ellinghausen-McCullough-Johnson-Harris (EMJH) medium are required, and cultures may take weeks to become positive. Culture is rarely used in routine clinical practice but remains important for research and surveillance.

Diagnostic Algorithm

The following Mermaid diagram outlines a recommended diagnostic workflow for a dog presenting with suspected leptospirosis.

flowchart TD
    A[Clinical Suspicion: Fever, AKI, Icterus, Pulmonary Signs], > B{Acute Phase < 7 days?}
    B, >|Yes| C[Blood PCR + Acute MAT]
    B, >|No| D[Urine PCR + Paired MAT]
    C, > E{Results}
    E, >|PCR positive or MAT >= 1:800| F[Presumptive Diagnosis]
    E, >|Negative| G[Repeat MAT in 2-4 weeks]
    D, > H{Results}
    H, >|PCR positive or 4-fold titer rise| F
    H, >|Negative| I[Consider alternative diagnoses]
    F, > J[Initiate treatment and report to public health]

Serovar Epidemiology

The distribution of Leptospira serovars in canine populations varies geographically and temporally. Historically, serovars Canicola and Icterohaemorrhagiae were most prevalent, but recent studies have documented a shift toward serovars Grippotyphosa, Pomona, and Australis in many regions [3, 6].

Regional Seroprevalence

A systematic review and meta-analysis of canine leptospirosis in China reported an overall seroprevalence of 12.5%, with serovars Australis and Grippotyphosa being most common [4]. In subtropical Mexico, seroprevalence in domiciled and stray dogs was 18.2%, with serovar Canicola predominating [10]. A study in the Yangtze River region of China found a seroprevalence of 15.3% and identified serovars Icterohaemorrhagiae and Pomona as the most prevalent [6]. In Northern Colombia, molecular surveillance of domestic dogs revealed a prevalence of 8.7% by PCR, with L. interrogans being the dominant species [12].

Outbreak Investigations

An outbreak of leptospirosis in dogs from Los Angeles County, California, USA, in 2021 was characterized clinically and molecularly. The outbreak involved multiple serovars, and genomic analysis of isolates revealed close relatedness to strains previously identified in wildlife, suggesting spillover from reservoir populations [3]. Genomic comparison of L. interrogans isolates from humans, dogs, and wild and feral animals in Japan demonstrated that canine isolates clustered with human and wildlife strains, supporting the role of dogs as bridging hosts in the transmission cycle [13].

Risk Factors

Risk factors for canine leptospirosis include exposure to stagnant water, contact with wildlife or livestock, and living in rural or peri-urban environments. A study on the risk of infection in dogs in contact with clinical canine leptospirosis cases found that in-contact dogs had a significantly higher odds of seroconversion compared to controls, emphasizing the need for biosecurity measures in multi-dog households [8]. Meteorological factors, including rainfall and temperature, have been shown to influence the incidence of leptospirosis in dog populations [2].

Vaccination Protocols

Vaccination is the cornerstone of leptospirosis prevention in dogs. Available vaccines are bacterins containing inactivated whole-cell preparations of multiple serovars. The most common formulations include quadrivalent vaccines covering serovars Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona.

Vaccine Efficacy and Limitations

Vaccination induces serovar-specific antibody responses that reduce the severity of disease and limit renal colonization and shedding. However, protection is serovar-restricted, and vaccines do not provide cross-protection against non-included serovars. The duration of immunity is typically 12 months, necessitating annual revaccination. Adverse reactions, including vaccine-associated hypersensitivity, are uncommon but recognized.

Vaccination Recommendations

The World Small Animal Veterinary Association (WSAVA) guidelines recommend leptospirosis vaccination as a core vaccine for dogs in endemic regions. Puppies should receive an initial series of two doses administered 2-4 weeks apart, starting at 8-12 weeks of age, followed by a booster at 12-16 weeks. Annual revaccination is recommended for dogs with ongoing exposure risk. In low-risk populations, a booster interval of 12-15 months may be considered.

Zoonotic Implications and One Health

Leptospirosis is a classic One Health disease, as it involves complex interactions between humans, animals, and the environment. Dogs serve as both sentinels and potential sources of human infection. Infected dogs can shed leptospires in urine for weeks to months after clinical recovery, contaminating household environments and public spaces [3, 4].

Public Health Risk

The risk of zoonotic transmission from dogs to humans is well documented. Direct contact with urine, contaminated water, or tissues of infected dogs can lead to human infection. Veterinary personnel, pet owners, and laboratory workers are at increased occupational risk. A One Health approach that integrates human, animal, and environmental surveillance is essential for effective prevention and control [14, 9].

Epidemiological Links

An epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia using a One Health approach demonstrated that the presence of seropositive dogs was a significant risk factor for human seropositivity [14]. Similarly, a serological investigation in a Fulni-ô Indigenous community in Brazil found that dogs seropositive for Leptospira spp. were spatially clustered with human cases, highlighting the role of dogs as indicators of environmental contamination [9].

Prevention Strategies

Prevention of zoonotic transmission requires a multi-pronged strategy. Vaccination of dogs reduces shedding and disease severity. Environmental management, including rodent control and avoidance of standing water, decreases the risk of exposure. Personal protective equipment (PPE) should be used when handling potentially infected animals or their urine. Public health education campaigns should emphasize the importance of hand hygiene and safe disposal of animal waste.

Conclusion

Canine leptospirosis remains a significant diagnostic and therapeutic challenge in veterinary medicine. The clinical presentation is variable, and a high index of suspicion is required for timely diagnosis. The MAT and PCR are complementary diagnostic tools, and their combined use improves diagnostic accuracy. The epidemiology of leptospirosis is dynamic, with shifting serovar distributions that necessitate ongoing surveillance. Vaccination is effective but serovar-restricted, and annual revaccination is recommended for at-risk dogs. The zoonotic potential of canine leptospirosis underscores the importance of a One Health approach that integrates veterinary, human, and environmental health sectors. Continued research into novel diagnostics, vaccines, and surveillance systems is essential for reducing the burden of this disease in both canine and human populations.

References

[1] Bringold C, Schweighauser A, Walther S, et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42224492/

[2] Hobson SJ, Zai B, Vyn CM, et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211529/

[3] Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/

[4] Wei W, Jiao D, Dong X, et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864068/

[5] Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W, et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637464/

[6] Ding Y, Zhang S, Zhang W, et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41383393/

[7] Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/

[8] Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41814781/

[9] Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/

[10] Andrade-Silveira E, Segura-Correa JC, Ortega-Pacheco A, et al. Seroprevalence of pathogenic leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359150/

[11] Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148179/

[12] Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K, et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557245/

[13] Kakita T, Takabe K, Morita M, et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41579465/

[14] Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC, et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42090421/

[15] Jost HE, Henriksen ML, Hawley J, et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: a pilot study. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41378760/